Feng Zhang (張鋒), a 2016 Tang Prize winner, explained his latest genome editing tool, called CRISPR/Cas13, in a meeting Wednesday with Tang Prize Foundation CEO Chern Jenn-chuan (陳振川) and a Nobel Prize laureate in Physiology or Medicine at the Massachusetts Institute of Technology (MIT).
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Culture
Students raise concerns at forum on school phone management rules
06/01/2025 04:52 PM - Politics
Taiwan Solidarity Union changes name to Taiwan Solidarity Party
06/01/2025 04:49 PM - Society
Police issue 26 traffic tickets to rider during street racing bust
06/01/2025 03:38 PM - Culture
Taiwan, Israel working holiday program opens for applications
06/01/2025 03:33 PM - Society
Rainy weather in parts of Taiwan on last day of long weekend: CWA
06/01/2025 01:10 PM